Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ICAM2 |
| Upstream (Parents) |
|---|
| (<<) ALDOA → ICAM2 |
| (<<) ARHGAP25 → ICAM2 |
| (<<) BCL2A1 → ICAM2 |
| (<<) CASP10 → ICAM2 |
| (<<) CD79A → ICAM2 |
| (<<) CLDN5 → ICAM2 |
| (<<) CORO1A → ICAM2 |
| (<<) CRLF3 → ICAM2 |
| (<<) HLA-DOA → ICAM2 |
| (<<) ISG20 → ICAM2 |
| (<<) ITGB7 → ICAM2 |
| (<<) JAK3 → ICAM2 |
| (<<) LTB → ICAM2 |
| (<<) MAP3K14 → ICAM2 |
| (<<) NDRG1 → ICAM2 |
| (<<) PRKCB → ICAM2 |
| (<<) PRKCQ → ICAM2 |
| (<<) PTGER4 → ICAM2 |
| (<<) STAT4 → ICAM2 |
| (<<) TNFAIP3 → ICAM2 |
| Downstream (Children) |
|---|
| ICAM2 → BMP2 (>>) |
| ICAM2 → CHST2 (>>) |
| ICAM2 → CREB5 (>>) |
| ICAM2 → CSTA (>>) |
| ICAM2 → DHRS9 (>>) |
| ICAM2 → FAM129B (>>) |
| ICAM2 → GLI3 (>>) |
| ICAM2 → GYPC (>>) |
| ICAM2 → HAS3 (>>) |
| ICAM2 → KHDRBS1 (>>) |
| ICAM2 → MREG (>>) |
| ICAM2 → NGFR (>>) |
| ICAM2 → PAG1 (>>) |
| ICAM2 → PLCG2 (>>) |
| ICAM2 → PRKACB (>>) |
| ICAM2 → STAT5A (>>) |
| ICAM2 → STK17B (>>) |
